Skip to main content
Download PDF

Seromolecular study on the prevalence and risk factors of Toxoplasma gondii infection in pregnant women referred to a gynecology hospital in Urmia, northwest part of Iran in 2022

BMC Infectious Diseases volume 24, Article number: 410 (2024) Cite this article

Abstract

Toxoplasmosis is a frequent infection among the human population. The infection can cause devastating complications for the fetus during pregnancy. The present study aimed to determine the serological and molecular prevalence of the infection and molecular characterization of Toxoplasma gondii isolates among pregnant women referred to Kowsar Hospital, Urmia, Iran. In a cross-sectional study, 340 blood samples were collected from pregnant women referred to Kowsar Hospital, Urmia, Iran from May to July 2022. Anti-T. gondii IgG and IgM seropositivity were determined by enzyme-linked immunosorbent assay. PCR was carried out by targeting the GRA6 gene of the parasite on all patients’ buffy coats. Anti-T. gondii IgG and IgM antibodies were positive in two (0.6%) women, and 101 (29.7%) women had anti-T. gondii IgG and 70.3% were seronegative. PCR was positive in two IgM-positive women, and both isolates belonged to T. gondii carrying the GRA6 allele of lineage I. The risk of infection was significantly higher in women who had constant contact with cats and soil, and who were residents of rural areas. The two IgM-positive women were asymptomatic regarding acute toxoplasmosis. According to the results of the present study, the prevalence of toxoplasmosis in pregnant women in Urmia is similar to its prevalence in other areas in northwestern Iran, and despite the low prevalence of acute infection, it should not be ignored.

Peer Review reports

Introduction

Toxoplasma gondii is an intracellular protozoan parasite with a variety of intermediate hosts that infects mammals and birds [1]. There are two stages in the life cycle of this parasite, the intestinal stage in the final host and the extraintestinal stage in intermediate hosts such as humans and other warm-blooded animals [2]. Transmission of T. gondii occurs mainly by ingestion of the oocysts excreted by cats or by consuming raw or undercooked meat of infected animals containing tissue cysts. Tachyzoites of the parasite may pass through the placenta of the infected pregnant women and infect the fetus causing congenital toxoplasmosis [3].

Acute infections with T. gondii that occur during pregnancy may sometimes cause congenital infection which may have severe complications such as fetal death, miscarriage, and ocular, neurological, and other organ damage in the fetus. If the infection occurs in the early stage of pregnancy, the transmission rate is low, yet if the fetus is infected in this period, the chance of severe infection is high. T. gondii infections that occur after birth are usually asymptomatic [4]. It is estimated that T. gondii infects approximately two billion humans worldwide, while only a very small percentage of infected individuals develop serious disease [5]. In immunocompromised patients, acute infection or activation of chronic infection may cause serious complications such as encephalitis [6].

T. gondii is divided into three main genetic lineages, types I, II, and III, which are different in terms of pathogenicity and epidemiological status. In South America, some lineages are distinct and non-type I, II, or III, which were named ‘atypical ’ or ‘exotic’ types. Type I is lethal to mice, yet types II and III are considerably less virulent. In humans, type II is the principal lineage causing toxoplasmosis. Nevertheless, type I or type I-like atypical isolates are more likely to severely cause retinochoroiditis in human patients. The atypical isolates are often reported to cause severe disseminated acute toxoplasmosis in patients with healthy immune systems [7]. Most of the strains isolated from patients with AIDS belong to type II. Types I and II strains have been recorded in patients with congenital infection [8]. In Iran, based on the reports from human and non-human samples, Type III had the highest frequency followed by Type I and then Type II. Mix and atypical types had the lowest frequency [9].

The diagnosis of T. gondii infection in humans is generally achieved by serological methods [10]. These methods are commonly intended to detect anti-Toxoplasma IgG and IgM. Although a positive IgM T. gondii antibody result indicates an acute infection, IgM can remain for several months. A positive T. gondii IgM and IgG result could not interpreted as an infection that recently occurred [11]. Molecular diagnosis, however, has significant advantages in the detection of toxoplasmosis [12].

Considering that a comprehensive study using serology and PCR together with an emphasis on diagnosing the acute form of the infection has not been conducted in West Azerbaijan Province, the present study aims to determine the prevalence of acute and chronic toxoplasmosis using serological and PCR methods and determine the genotype of the parasite in pregnant women referred to Kowsar Hospital in Urmia.

Materials and methods

Study area and sample collection

This cross-sectional survey was carried out in Urmia, the capital of West Azerbaijan Province, North West Iran. The study was approved by the Ethics Committee of Urmia University of Medical Sciences under the Ethical Code of IR.UMSU.REC.1401.031. Participants were informed about the study and a signed informed consent was obtained from them.

Blood of 340 pregnant women of all gestational ages referred to Kowsar Hospital was collected during two months from May to July 2022. Blood samples were taken from pregnant women and divided into two parts; one for serum separation and the other for buffy coat isolation. The sera were separated from whole blood, and buffy coats were isolated by centrifugation of blood containing anti-coagulant and kept frozen at -70 °C until examination.

Serological assays

ELISA was carried out on the collected sera for anti-T. gondii IgG and IgM antibodies, using commercial kits (Pishtazteb, Iran) following the manufacturer’s instructions. The anti-Toxoplasma IgG indirect ELISA kit was used with a sensitivity of 100% and specificity of 99% as claimed by the company. The kits contained standards (10, 50, 100, and 200 IU/mL) positive and negative controls. IgG antibody concentrations ​​higher than 11 were considered positive, ​​those between 9 and 11 were considered borderline, and those less than 9 were considered negative. The qualitative antibody capture anti-Toxoplasma IgM ELISA kit was 100% sensitive and 99% specific as claimed by the company. The kit contained three controls (negative, positive, and cut-off controls). Seropositivity was calculated based on the cutoff controls as follows. Cutoff index = sample OD/mean OD of cutoffs. An index higher than 1.1 was considered positive, less than 0.9 was considered negative and between 0.9 and 1.1 was considered borderline.

DNA extraction and PCR

The genomic DNA from all 340 buffy coat samples of the pregnant woman was extracted using a commercial DNA extraction kit (NodexPlus, NAT Biotech, Iran) according to the instructions of the kit. The PCR test was performed using the GRA6 gene of T. gondii that was previously described as a nested PCR; however, in the present study, the inner primers targeting 344 bp sequence with annealing at 55 °C were used (F: TTTCCGAGCAGGTGACCT and R: TCGCCGAAGAGTTGACATAG) [13]. PCR was performed in a final volume of 20 µL, including 10 µL of premix (Ampliqon, Denmark), 1 µL of forward primer and 1 µL of reverse primer, 2 µL of template DNA, 4 µL of Q-solution and 2 µL of distilled water. The T. gondii RH strain and nuclease-free water were used as the positive and negative controls, respectively.

The thermal cycles were as follows. An initial denaturation at 95 °C for 5 min, 35 cycles of denaturation at 95 °C for 30 s, annealing at 55 °C for 30 s, extension at 72 °C for 30 s, and a final extension at 72 °C for 5 min. Then gel electrophoresis was carried out on the PCR products in a 1.5% agarose gel in TBE buffer.

Sequencing

PCR-positive samples were reamplified in a volume of 50 µl and sequenced by the Sanger sequencing method with the forward primer. The obtained sequences were initially visually checked for any noise and low-quality peaks using SnapGene software v. 5.3.1 (available at www.snapgene.com), imported into MEGA11 (Tamura, Stecher, and Kumar 2021) [14], edited on both sides and aligned using ClustalW. The sequences were then compared with sequences from GenBank for closest genetic relatives and then deposited to the GenBank. A phylogenetic tree was built by the maximum likelihood method using the Tamura–Nei model (MEGA11) [15].

In silico restriction fragment length polymorphism (RFLP)

In silico RFLP simulation was performed in SnapGene software using Tru1I (MseI) restriction endonuclease. The 2.5% agarose gel electrophoresis was created and exported as an image file.

Data analysis

Data were analyzed by SPSS version 23 (IBM Corp. Released 2020. IBM SPSS Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp) using chi-square, t- and logistic regression tests. P value < 0.05 was considered significant.

Results

Regional distribution

The studied population was referred from different regions of West Azerbaijan Province, which are listed in Table 1.

Serology

Sera were collected from 340 pregnant women with an average age of 29.13 ± 6.65 years (16–46 years old) who were in different months of gestation. Out of 340 tested samples, both anti-T. gondii IgG and IgM antibodies were positive in two (0.6%) women and 101 (29.7%) women had anti-T. gondii IgG. T. gondii IgG seropositivity in different districts is available in Table 1.

T. gondii seropositivity was significantly higher in women who resided in rural regions (OR = 1.538; P = 0.049) and had contact with soil (OR = 2.043; P = 0.003 ) and cats (OR = 1.757; P = 0.014). The prevalence was lower in women who washed raw consumed vegetables with disinfectants, yet it was not statistically significant (OR = 0.417; P = 0.162). Additionally, no significant difference was found between T. gondii seropositivity and the consumption of undercooked meat (Table 1).

Table 1 Anti-T. gondii seropositivity among pregnant women considering different studied demographics and risk factors, in West Azerbaijan province, Northwest Iran. The odds ratio can be inversed by 1 ÷ OR
Full size table

Using the Kolmogorov‒Smirnov test, the normality of the data related to the age of the patients was checked, and the results showed that the data related to the age of the patients did not have a normal distribution (P < 0.001). Therefore, the nonparametric Mann‒Whitney U test was used to compare the average age among toxoplasmosis-positive and toxoplasmosis-negative people. The average age of the positive and negative studied women did not show any significant difference (Table 2).

Table 2 Comparison of mean age of toxoplasmosis-positive and toxoplasmosis-negative pregnant women in Urmia
Full size table

The mean concentration of IgG in T. gondii IgG-positive people was 54.22 ± 2 IU/mL. The normality of these data was evaluated by the Kolmogorov‒Smirnov test and the results showed that the distribution of IgG concentration data in positive pregnant women was normal (P = 0.2). Therefore, the t-test and analysis of variance (ANOVA) were used to analyze the relevant data. Using the t-test, the average IgG concentration was not significantly different regarding different risk factors such as having contact with cats and soil, living in rural areas, and consumption of undercooked meat (Table 3).

Table 3 Comparison of the mean concentration of anti-T. gondii IgG of positive women with the studied risk factors
Full size table

ANOVA was used to compare the mean IgG concentration in variables with more than two variants. The results showed a lower concentration of anti-T. gondii IgG among patients who used disinfectants for washing vegetables compared to those who used water (P = 0.008) and salt (P = 0.016) (Table 4).

Table 4 Comparison of the mean concentration of anti-T. gondii IgG of positive women with different methods of washing vegetables
Full size table

PCR

PCR was performed on all 340 blood samples of the studied pregnant women on the GRA6 gene (344 bp fragment). None of those women that were solely positive for anti-T. gondii IgG was positive in the PCR and only the two IgM-positive samples (0.6%) were found to be PCR positive (Fig. 1).

Fig. 1
figure 1

Gel electrophoresis of positive samples (S) along with positive control (Pc), negative control (Nc), and bp100 marker (M)

Full size image

Sequencing

After editing both sides of the two sequences, 288 bp remained. The sequences were then compared to the reference sequences of the GenBank and both were found to be 100% homologous with the type I of T. gondii (Fig. 2), however, because the sequence is short and there may be common sequences among different types, it could be a GRA6 allele of type I.

The sequences were deposited to the GenBank under the accession numbers of OR701824 and OR701825.

Fig. 2
figure 2

Phylogenetic analysis of two human isolates (pregnant women) of T. gondii using the 288 bp fragment of GRA6 gene sequence. The maximum likelihood method and Tamura-Nei model were used to infer the evolutionary history [15]. The phylogenetic tree with the highest log likelihood (-429.09) is illustrated in the figure. This analysis was carried out on the five nucleotide sequences. There were 288 positions in the sequences. Evolutionary analyses were conducted in MEGA11 [14]. The isolates (37 and 41) under the accession numbers of OR701824 and OR701825 are the isolates of the present study

Full size image

In silico RFLP

The sequences of two isolates each 288 bp and controls from the gene bank for each type I, II, and III of T. gondii were simulated in 2.5% agarose gel after being digested with Tru1I (MseI) endonuclease using SnapGene software. The endonuclease cleaved and produced two 201 and 87 bp fragments for type I, two 184 and 104 bp fragments for type II, and three 104, 97, and 87 bp fragments for type III (Fig. 3).

Fig. 3
figure 3

Software simulation of gel electrophoresis of the enzymatic digestion by endonuclease Tru1I (MseI) in the in silico RFLP on the 288 bp fragment of GRA6 gene of T. gondii. Lane MW and 6: 50 bp DNA marker; lane 1 (type I: MH429064.1), 4 (type II: MH429061.1), and 5 (Type III: MH429071.1): controls; lane 2 and 3: isolates of the present study

Full size image

Discussion

Toxoplasmosis is a zoonotic infection with a wide geographic distribution. Humans acquire the infection in different ways such as eating raw or undercooked meat containing tissue cysts (bradyzoites) or ingesting oocysts in contaminated soil, water, or food [16]. Infection in pregnant women can cause serious complications in the fetus such as miscarriage, mental retardation, and eye and nervous system damage [17].

In the present study, out of 340 blood samples of pregnant women that were tested, 29.7% had a positive level of IgG and 0.6% had a positive level of IgM against T. gondii. The highest infection rate was related to women who lived in rural areas. In a study conducted on pregnant women referred to Al-Zahra Medical Center in Tabriz in 2011, 26.3% of the studied pregnant women had a positive IgG titer and 0.33% had a positive IgM titer. T. gondii infection seropositivity was higher in pregnant women in contact with cats [18]. In another similar study conducted by Hazrati Teppeh et al. 2014 on pregnant women in Urmia, 28.32% of the studied population was anti-T. gondii IgG positive and 1.44% was IgM positive [19]. In our study, the IgG and IgM titers were similar to those in the two studies mentioned in Tabriz and Urmia.

Considering studies from different regions of Iran, the prevalence of toxoplasmosis in pregnant women was reported to be 31.1% in Tehran in 2010–2013 [20], 41.8% in Gorgan in 2012 [21], 32% in Yazd in 2012 [22], and 37.2% in Zanjan in 2012 [23]. The reported prevalence of toxoplasmosis in pregnant women is different among countries. For example, the prevalence of toxoplasmosis in pregnant women was reported to be 70.8% in northwest Ethiopia in 2019 [24], 70.8% in Brazil from October 2004 to April 2005 [25], and 55% in India from January 2005 to 2006 [26].

The most important factors involved in the spread of toxoplasmosis are geographical conditions, humidity level, heat, food habits, and hygiene practices [27]. The results of our study showed that there is no significant relationship between the consumption of undercooked meat and the method of washing vegetables with toxoplasmosis, which is different from the results of a report from Fallah et al. in 2004 in Hamedan, West of Iran [28]. In the present study, there was a significant relationship between contact with a cat and acquiring T. gondii infection, which is in contrast with the report of Cheraghipour et al. 2010 in Khorramabad, western Iran [29]. The results of our study showed that there is a significant relationship between being commonly in contact with soil and toxoplasmosis, which was consistent with the results of the study by Sharbat Khouri et al. in 2012 in Gorgan City, Golestan Province [21] and also in 2012 in Tabriz, a neighboring city [30].

In this research, molecular diagnosis and identification of T. gondii were performed by targeting the GRA6 gene in all 340 samples. In two cases that were IgM positive, the infection was also positive with PCR. In a study conducted by Turcekova and colleagues in 2012 in Kosice, 15 amniotic fluids and 1 blood sample from pregnant women suspected of toxoplasmosis were analyzed. The presence of T. gondii in the blood of a pregnant woman was confirmed and identified as genotype I, which is the same genotype identified in the present study in two pregnant women [31].

Jawahir Alghamdi et al. in Saudi Arabia in 2011, reported the seroprevalence of T. gondii IgG and IgM antibodies in 32.5% and 6.4% of pregnant women, respectively [32]. Contrary to the finding of the present study, in their report, 29 samples (80.6%) out of 203 pregnant women were genotype II, and 7 samples (19.4%) were genotype III [32]. Furthermore, T. gondii DNA was reported in 3.8% (8/210) of paraffin-embedded fetoplacental tissues of women with recurrent spontaneous abortion, which all positive samples belonged to type III [33], which is different from the genotype found in the present study (type I). Based on the review by Sadeghi et al. 2022, among the genotypes reported from Iran on human and non-human samples, type III had the highest frequency followed by Type I and then Type II [9].

In 2004 Asmar et al. performed a serological examination of sera from 200 pregnant women referred to the Department of Parasitology, Pasteur Institute of Iran, using IFA and reported positive serum antibody titers against T. gondii in 49 (24.5%) of their studied samples. Subsequently, nested PCR targeting the B1 gene was performed on 11 samples of amniotic fluid from women with anti-T. gondii IgM, of which four samples were found to be positive [34]. In the present study, amniotic fluid was not used, however, both IgM-positive women were also positive by PCR, and all of the solely IgG-positive ones were negative in the PCR.

In the study of Aref Khah et al., 100 tissue samples of spontaneously aborted fetuses and their mother’s blood were analyzed in Kohgiluyeh and Boyer Ahmed Province from 2015 to 2016. Mothers’ sera were examined for anti-T. gondii antibodies, while fetal tissues were examined for the presence of T. gondii DNA. They performed PCR targeting the GRA6 gene and then sequenced them. Seven percent of their studied women were IgG and 3% were IgM positive. Using real-time PCR on the buffy coat, one seronegative case and two IgM-positive cases (out of three cases) were also positive for T. gondii, which were related to genotype I, similar to the findings of the present study. In Arif Khah et al. study, as in our study, DNA was extracted from all samples and PCR was performed on all studied populations. In their study, a seronegative individual was positive by PCR [35]; however, in the present study, only IgM-positive individuals were also positive by PCR.

Limitations of the study

We had two main limitations; first, we could not follow up with the two pregnant IgM-positive women to see whether after delivery their infant was healthy or with congenital toxoplasmosis. The second limitation was not using other genetic markers rather than GRA6 alone. Performing multilocus genotyping would result in more accurate genotype characteristics than a single gene.

Conclusion

According to the results of the present study, the prevalence of toxoplasmosis in pregnant women in Urmia is similar to its prevalence in other areas in the northwest of the country, and despite the low prevalence of acute infection, due to possible serious complications on the fetus, it should not be ignored. Living in rural areas, contact with cats, contact with the soil, and not washing vegetables with vegetable disinfectants can increase the risk of toxoplasmosis. In the present study isolates carrying the GRA6 allele of Lineage I were identified in pregnant women in West Azerbaijan Province; however It is necessary to examine more samples for evaluation of Toxoplasma genotypes.

Data availability

The datasets, raw or analyzed will be available from the corresponding author on reasonable request.

References

  1. Su C, Dubey JP. Isolation and Genotyping of Toxoplasma gondii Strains. Methods in molecular biology (Clifton, NJ) 2020, 2071:49–80.

  2. Attias M, Teixeira DE, Benchimol M, Vommaro RC, Crepaldi PH, De Souza W. The life-cycle of Toxoplasma Gondii reviewed using animations. Parasites Vectors. 2020;13(1):588.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hill D, Dubey JP. Toxoplasma Gondii: transmission, diagnosis and prevention. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2002;8(10):634–40.

    Article  CAS  Google Scholar 

  4. Dubey JP, Murata FHA, Cerqueira-Cézar CK, Kwok OCH, Villena I. Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections. Parasitology. 2021;148(12):1406–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Smith NC, Goulart C, Hayward JA, Kupz A, Miller CM, van Dooren GG. Control of human toxoplasmosis. Int J Parasitol. 2021;51(2–3):95–121.

    Article  CAS  PubMed  Google Scholar 

  6. Machala L, Kodym P, Malý M, Geleneky M, Beran O, Jilich D. [Toxoplasmosis in immunocompromised patients]. Epidemiologie Mikrobiologie Imunologie: casopis Spolecnosti pro epidemiologii mikrobiologii Ceske lekarske spolecnosti JE Purkyne. 2015;64(2):59–65.

    CAS  Google Scholar 

  7. Su C, Shwab EK, Zhou P, Zhu XQ, Dubey JP. Moving towards an integrated approach to molecular detection and identification of Toxoplasma Gondii. Parasitology. 2010;137(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  8. Lampejo T. Toxoplasma Gondii infection in HIV-infected pregnant women: epidemiology and risks of mother-to-child transmission. Pan Afr Med J. 2022;42:275.

    PubMed  PubMed Central  Google Scholar 

  9. Sadeghi M, Hosseini SA, Sarvi S, Nayeri T, Sharif M, Pagheh AS, Amouei A, Montazeri M, Daryani A. More than seventy years of Research (1948-November 2021) on Toxoplasma Gondii in Iran: a narrative review. Iran J Parasitol. 2022;17(2):124–37.

    PubMed  PubMed Central  Google Scholar 

  10. Liu Q, Wang ZD, Huang SY, Zhu XQ. Diagnosis of toxoplasmosis and typing of Toxoplasma Gondii. Parasites Vectors. 2015;8:292.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Beder D, Esenkaya Taşbent F. General Features and Laboratory Diagnosis of Toxoplasma gondii infection. Turkiye Parazitolojii Dergisi. 2020;44(2):94–101.

    Article  PubMed  Google Scholar 

  12. Kong QM, Lu SH, Tong QB, Lou D, Chen R, Zheng B, Kumagai T, Wen LY, Ohta N, Zhou XN. Loop-mediated isothermal amplification (LAMP): early detection of Toxoplasma gondii infection in mice. Parasites Vectors. 2012;5:2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Khan A, Su C, German M, Storch GA, Clifford DB, Sibley LD. Genotyping of Toxoplasma gondii strains from immunocompromised patients reveals high prevalence of type I strains. J Clin Microbiol. 2005;43(12):5881–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Tamura K, Stecher G, Kumar S. MEGA11: Molecular Evolutionary Genetics Analysis Version 11. Mol Biol Evol. 2021;38(7):3022–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol. 1993;10(3):512–26.

    CAS  PubMed  Google Scholar 

  16. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet (London England). 2004;363(9425):1965–76.

    Article  CAS  PubMed  Google Scholar 

  17. Hampton MM. Congenital toxoplasmosis: a review. Neonatal Netw NN. 2015;34(5):274–8.

    Article  PubMed  Google Scholar 

  18. Dalimiasl A. Sero-epidemiology of Toxoplasma Infection in PregnantWomen Referred to Al Zahra Hospital in Tabriz. 2012.

  19. Hazrati Tappeh K, Mousavi SJ, Bouzorg Omid A, Ali Nejad V, Alizadeh H. Seroepidemiology and risk factors of toxoplasmosis in pregnant women in Urmia City. Stud Med Sci. 2015;26(4):296–302.

    Google Scholar 

  20. Ghasemloo H, Ghomashlooyan M, Hooshyar H. Seroprevalence of Toxoplasma Gondii infection among pregnant women admitted at Shahid Akbar Abadi hospital, Tehran, Iran, 2010–2013. J Med Microbiol Infect Dis. 2014;2(1):16–8.

    Google Scholar 

  21. Sharbatkhori M, Moghaddam YD, Pagheh AS, Mohammadi R, Mofidi HH, Shojaee S. Seroprevalence of Toxoplasma gondii infections in pregnant women in Gorgan city, Golestan Province, northern Iran-2012. Iran J Parasitol. 2014;9(2):181.

    PubMed  PubMed Central  Google Scholar 

  22. AnvariTafti M, Ghafourzadeh M. Seroepidemiology of Toxoplasma infection in pregnant women in Yazd in 2012. Tolooebehdasht. 2014;13(3):116–25.

    Google Scholar 

  23. Hajsoleimani F, Ataeian A, Nourian A, Mazloomzadeh S. Seroprevalence of Toxoplasma Gondii in pregnant women and bioassay of IgM positive cases in Zanjan, Northwest of Iran. Iran J Parasitol. 2012;7(2):82.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Adugna B, Tarekegn ZS, Damtie D, Woldegebreal SN, Raju RP, Maru M, Ayele A. Seroepidemiology of Toxoplasma gondii among pregnant women attending Antenatal Care in Northwest Ethiopia. Infect drug Resist. 2021;14:1295–303.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Porto AM, Amorim MM, Coelho IC, Santos LC. [Serologic profile of toxoplasmosis in pregnant women attended at a teaching-hospital in Recife]. Revista da Associacao Medica Brasileira (1992) 2008, 54(3):242–248.

  26. Khurana S, Bagga R, Aggarwal A, Lyngdoh V, Diddi K, Malla N. Serological screening for antenatal toxoplasma infection in India. Ind J Med Microbiol. 2010;28(2):143–6.

    Article  CAS  Google Scholar 

  27. Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Fallah M, Rabiee S, Matini M, Taherkhani H. Seroepidemiology of toxoplasmosis in primigravida women in Hamadan, Islamic Republic of Iran, 2004. EMHJ-Eastern Mediterranean Health Journal, 14 (1), 163–171, 2008 2008.

  29. Cheraghipour K, Taherkhani H, Fallah M, Sheikhian A, Sardarian K, Rostami Nejad M, Maghsood A. Seroprevalence of toxoplasmosis in pregnant women admitted to the Health centers of Khorram-Abad City, Iran. Avicenna J Clin Med. 2010;17(3):46–51.

    Google Scholar 

  30. Jafari R, Sadaghian M, Safari M. Seroprevalence of Toxoplasma gondii infection and related risk factors in Tabriz City, Iran, 2008. J Res Health Sci. 2012;12(2):119–21.

    PubMed  Google Scholar 

  31. Turcekova L, Spisak F, Dubinsky P, Ostro A. Molecular diagnosis of Toxoplasma Gondii in pregnant women. Bratisl Lek Listy. 2012;113(5):307–10.

    CAS  PubMed  Google Scholar 

  32. Alghamdi J, Elamin MH, Alhabib S. Prevalence and genotyping ofToxoplasma gondii among Saudi pregnant women in Saudi Arabia. Saudi Pharm Journal: SPJ: Official Publication Saudi Pharm Soc. 2016;24(6):645–51.

    Google Scholar 

  33. Abdoli A, Dalimi A, Soltanghoraee H, Ghaffarifar F. Molecular detection and genotypic characterization of Toxoplasma Gondii in paraffin-embedded fetoplacental tissues of women with recurrent spontaneous abortion. Int J Fertil Steril. 2017;10(4):327–36.

    CAS  PubMed  Google Scholar 

  34. Asmar M, Yassaei F, Terhovanesian A, ESMAILI A, HASAN N, Farzanehnezhaad Z, NADAF S. Prenatal diagnosis of congenital toxoplasmosis: validity of PCR using amniotic fluid against indirect fluorescent antibody assay in mothers. 2004.

  35. Arefkhah N, Pourabbas B, Asgari Q, Moshfe A, Mikaeili F, Nikbakht G, Sarkari B. Molecular genotyping and serological evaluation of Toxoplasma Gondii in mothers and their spontaneous aborted fetuses in Southwest of Iran. Comp Immunol Microbiol Infect Dis. 2019;66:101342.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the Vice-Chancellor of Research and Technology of Urmia University of Medical Sciences, Urmia, Iran, for approval and financial support (Research no: 2993, ethical code: IR.UMSU.REC.1401.031) of this study and to Kowsar Hospital for their help and contribution.

Funding

The present study was approved and financially supported by the Vice-Chancellor of Research and Technology of Urmia University of Medical Sciences, Urmia, Iran, under Research no 2993.

Author information

Authors and Affiliations

  1. Department of Parasitology and Mycology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran

    Nasim Bashour, Arash Aminpour & Rasool Jafari

  2. Department of Obstetrics and Gynecology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran

    Shabnam Vazifehkhah

  3. Cellular and Molecular Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran

    Rasool Jafari

Authors
  1. Nasim Bashour
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arash Aminpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shabnam Vazifehkhah
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rasool Jafari
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

N.B. collected samples, filled out questionnaires, conducted laboratory work, and prepared the manuscript draft. R.J., A.A., and S.V. supervised the study. R.J. conceptualization, confirmed the diagnoses, analyzed the data and edited the manuscript.

Corresponding author

Correspondence to Rasool Jafari.

Ethics declarations

Ethics approval and consent to participate

All methods in the present study were carried out in accordance with relevant guidelines and regulations of the Iran National Committee for Ethics in Biomedical Research. The study was approved by the Ethics Committee of Urmia University of Medical Sciences under the Ethical Code of IR.UMSU.REC.1401.031. Participants were informed about the study and a signed informed consent was obtained from them.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bashour, N., Aminpour, A., Vazifehkhah, S. et al. Seromolecular study on the prevalence and risk factors of Toxoplasma gondii infection in pregnant women referred to a gynecology hospital in Urmia, northwest part of Iran in 2022. BMC Infect Dis 24, 410 (2024). https://doi.org/10.1186/s12879-024-09265-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-024-09265-5

Keywords

BMC Infectious Diseases

ISSN: 1471-2334

Contact us